Since December 2019, the world has faced a pandemic of COVID-19, an infectious disease caused by SARS-CoV-2, a virus that emerged in China. The reference diagnosis is based on the search for the SARS-COV-2 genome in the nasopharyngeal sample. Carrying out this sample requires the competence of a healthcare professional and presents some inconveniences for the tested patient. Because saliva collection is simple, non-invasive, painless and inexpensive, and can be performed by poorly trained personnel, it could be an alternative to the reference nasopharyngeal sample. SARS-CoV2 detection in human saliva could be a potential diagnosis of COVID infection.
Inclusion Criteria:
- patient hospitalized at the Amiens CHU in a COVID-19 unit
- patient seen as outpatient in the area of infectious pathologies for COVID-19
infection
Exclusion Criteria:
- Patients under 18
- patients under guardianship or curators
CHU Amiens
Amiens, France